Merck & Co Inc (MRK)
108.66
-1.35
(-1.23%)
USD |
NYSE |
Jun 07, 15:36
Merck PE Ratio: 21.22 for June 7, 2023
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| June 06, 2023 | 21.49 |
| June 05, 2023 | 22.09 |
| June 02, 2023 | 21.98 |
| June 01, 2023 | 21.67 |
| May 31, 2023 | 21.56 |
| May 30, 2023 | 21.32 |
| May 26, 2023 | 21.69 |
| May 25, 2023 | 21.93 |
| May 24, 2023 | 22.19 |
| May 23, 2023 | 22.12 |
| May 22, 2023 | 22.36 |
| May 19, 2023 | 22.56 |
| May 18, 2023 | 22.27 |
| May 17, 2023 | 22.41 |
| May 16, 2023 | 22.67 |
| May 15, 2023 | 22.73 |
| May 12, 2023 | 22.88 |
| May 11, 2023 | 22.96 |
| May 10, 2023 | 23.03 |
| May 09, 2023 | 22.94 |
| May 08, 2023 | 23.12 |
| May 05, 2023 | 22.98 |
| May 04, 2023 | 22.92 |
| May 03, 2023 | 23.09 |
| May 02, 2023 | 23.03 |
| Date | Value |
|---|---|
| May 01, 2023 | 22.72 |
| April 28, 2023 | 22.55 |
| April 27, 2023 | 22.49 |
| April 26, 2023 | 22.15 |
| April 25, 2023 | 22.76 |
| April 24, 2023 | 22.64 |
| April 21, 2023 | 22.53 |
| April 20, 2023 | 22.30 |
| April 19, 2023 | 22.29 |
| April 18, 2023 | 22.43 |
| April 17, 2023 | 22.46 |
| April 14, 2023 | 22.52 |
| April 13, 2023 | 22.57 |
| April 12, 2023 | 22.22 |
| April 11, 2023 | 21.97 |
| April 10, 2023 | 21.99 |
| April 06, 2023 | 21.94 |
| April 05, 2023 | 21.86 |
| April 04, 2023 | 21.26 |
| April 03, 2023 | 21.26 |
| March 31, 2023 | 20.78 |
| March 30, 2023 | 18.55 |
| March 29, 2023 | 18.37 |
| March 28, 2023 | 18.48 |
| March 27, 2023 | 18.73 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
12.94
Minimum
Sep 21 2022
121.80
Maximum
Sep 21 2018
29.24
Average
22.40
Median
PE Ratio Benchmarks
| Amgen Inc | 15.04 |
| Johnson & Johnson | 33.17 |
| Eli Lilly and Co | 70.64 |
| Prometheus Biosciences Inc | -- |
| Moderna Inc | 10.89 |
PE Ratio Related Metrics
| PS Ratio | 4.779 |
| Price to Book Value | 5.887 |
| Price to Free Cash Flow | 24.56 |
| Price | 108.66 |
| Earnings Yield | 4.71% |
| Market Cap | 275.72B |
| Operating PE Ratio | 16.80 |
| Normalized PE Ratio | 19.97 |